Breast cancer, Her2 positive, Neoadjuvant, Nab-paclitaxel, De-escalation
Breast cancer, Breathomics, Volatile organic compounds, Diagnosis, Progression monitoring
Young breast cancer, Global burden, Trends, Risk factor
breast cancer, Neoadjuvant Chemotherapy, Pathological complete response, Next-Generation Sequencing, Deep Learning